Badranjboya with Amlodipine in the management of Blood pressure

To Evaluate Adjuvant Effect of Badranjboya with Amlodipine in Primary Hypertension: A Randomized Standard Control Study.

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2018/03/012472

Enrollment

Registered

2018-03-12

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- Stage-I Primary Hypertension

Interventions

Intervention1: Badranjboya (Mellisa officinalis) withAmlodipine: Decoction of 10gm of Badranjboya (Mellisa officinalis) OD daily orally in the morning for 28days with Amlodipine 5mg tablet OD daily or

Eligibility

Inclusion criteria

Inclusion criteria: Patients of either sex between the age group of 35-60 years. Patients diagnosed with stage-I primary Hypertension.

Exclusion criteria

Exclusion criteria: Patients with any systemic illnesses, secondary diseases. Patients who have malignant hypertension Lactating and pregnant women. H/o acute cerebrovascular events, vasospastic angina, valvular diseases.

Design outcomes

Primary

Measure	Time frame
Blood PressureTimepoint: 0, 7th,14th , 21st and 28th day	—

Secondary

Measure	Time frame
Change in subjective parametersTimepoint: 0, 7th,14th , 21st and 28th day	—

Countries

India

Contacts

Public ContactArshid Iqbal Wani

Luqman Unani Medical College, Hospital and Research Centre

arshidwani456@gmail.com9742863126

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026